P S Prabhakaran1, S Misra, V Kannan
1Department of Surgical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study of sacral chordoma patients found a 5-year overall survival of 48%. Curative therapies improved survival but local recurrence and distant metastasis remained significant challenges.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: